{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:47:00Z","timestamp":1789786020892,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":538,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.14283\/jpad.2023.22","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:09:15Z","timestamp":1676524155000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Forecasting the Prevalence of Alzheimer's Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022"],"prefix":"10.1016","volume":"10","author":[{"given":"Audrey","family":"Gabelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gu\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Doutriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bettayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.14283\/jpad.2023.22_bib1","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","article-title":"Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium","volume":"95","author":"Wolters","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib2","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1038\/ncomms11398","article-title":"A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II","volume":"7","author":"Matthews","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.14283\/jpad.2023.22_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1504327","article-title":"Incidence of Dementia over Three Decades in the Framingham Heart Study","volume":"374","author":"Satizabal","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.14283\/jpad.2023.22_bib4","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"issue":"6","key":"10.14283\/jpad.2023.22_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10654-013-9818-7","article-title":"20-Year prevalence projections for dementia and impact of preventive policy about risk factors","volume":"28","author":"Jacqmin-Gadda","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.14283\/jpad.2023.22_bib6","article-title":"Assessing the socioeconomic impact of Alzheimer's disease in Western Europe and Canada","author":"The Economist Intelligence Unit","year":"2017","journal-title":"The Economist"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/fhep-2014-0013","article-title":"The Value of Delaying Alzheimer's Disease Onset","volume":"18","author":"Zissimopoulos","year":"2014","journal-title":"Forum Health Econ Policy"},{"issue":"4","key":"10.14283\/jpad.2023.22_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.14283\/jpad.2023.22_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.14283\/jpad.2023.22_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/ipm.2018.4","article-title":"The Lancet Commission on Dementia Prevention, Intervention, and Care: a call for action","volume":"36","author":"Orgeta","year":"2019","journal-title":"Ir J Psychol Med"},{"key":"10.14283\/jpad.2023.22_bib11","author":"Ankri"},{"key":"10.14283\/jpad.2023.22_bib12","author":"Grand"},{"key":"10.14283\/jpad.2023.22_bib13","author":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9"},{"key":"10.14283\/jpad.2023.22_bib14","unstructured":"Carcaillon-bentata L, Elbaz A, Ha C, et al. Peut-on estimer la pr\u00e9valence de la maladie d'Alzheimer et autres d\u00e9mences \u00e0 partir des bases de donn\u00e9es m\u00e9dico-administratives? Comparaison aux donn\u00e9es de cohortes populationnelles. Bulletin \u00e9pid\u00e9miologique hebdomadaire (BEH). 2016;(n\u00b0 28\u201329):459\u2013467."},{"issue":"4","key":"10.14283\/jpad.2023.22_bib15","first-page":"405","article-title":"[Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort]","volume":"159","author":"Ramaroson","year":"2003","journal-title":"Rev Neurol (Paris)"},{"issue":"Suppl1","key":"10.14283\/jpad.2023.22_bib16","first-page":"S73","article-title":"LP22- UPDATED U.S. PREVALENCE ESTIMATES ACCOUNTING FOR RACIAL AND ETHNIC DIVERSITY FOR TRIALS AND THERAPIES TARGETING MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE (AD) AND MILD AD DEMENTIA","volume":"8","author":"Gillis","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2023.22_bib17","doi-asserted-by":"crossref","first-page":"S633","DOI":"10.1016\/j.jval.2020.08.1384","article-title":"PND59 Estimating the Prevalence of A\u03b2-Confirmed Alzheimer's Disease Using a Funnel-Based Approach","volume":"23","author":"Potashman","year":"2020","journal-title":"Value in Health"},{"issue":"3","key":"10.14283\/jpad.2023.22_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.22_bib19","unstructured":"HAS. Transparency Committee doctrine_Principles of medicinal product assessments and appraisal for reimbursement purposes. 2020:28."},{"issue":"3","key":"10.14283\/jpad.2023.22_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2023.22_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum","volume":"79","author":"Jansen","year":"2022","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.14283\/jpad.2023.22_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2023.22_bib24","author":"Alzheimer Europe"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00415-013-7160-3","article-title":"Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study","volume":"261","author":"Mouton-Liger","year":"2014","journal-title":"J Neurol"},{"issue":"13","key":"10.14283\/jpad.2023.22_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JAD-190430","article-title":"Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1","volume":"72","author":"Robinson","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2023.22_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1051\/medsci\/2006223288","article-title":"\u00c9pid\u00e9miologie de la maladie d'Alzheimer et des syndromes apparent\u00e9s","volume":"22","author":"Helmer","year":"2006","journal-title":"Med Sci (Paris)"},{"issue":"6","key":"10.14283\/jpad.2023.22_bib29","doi-asserted-by":"crossref","first-page":"e029663","DOI":"10.1136\/bmjopen-2019-029663","article-title":"How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years","volume":"9","author":"Epelbaum","year":"2019","journal-title":"BMJ Open"},{"key":"10.14283\/jpad.2023.22_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12613","article-title":"Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study","author":"Hanon","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.14283\/jpad.2023.22_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jalz.2018.01.004","article-title":"Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers","volume":"14","author":"Hanon","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13195-017-0288-0","article-title":"Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort","volume":"9","author":"Dufouil","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"10.14283\/jpad.2023.22_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/WNL.0b013e3181f11d85","article-title":"Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging","volume":"75","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2023.22_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/01.WNL.0000132523.27540.81","article-title":"Mild cognitive impairment, amnestic type: an epidemiologic study","volume":"63","author":"Ganguli","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2023.22_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.45.4.741","article-title":"Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland","volume":"45","author":"Koivisto","year":"1995","journal-title":"Neurology"},{"issue":"22","key":"10.14283\/jpad.2023.22_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.wnl.0000263132.99055.0d","article-title":"CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia","volume":"68","author":"Di Carlo","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.14283\/jpad.2023.22_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1212\/01.WNL.0000034176.07159.F8","article-title":"Incidence and outcome of mild cognitive impairment in a population-based prospective cohort","volume":"59","author":"Larrieu","year":"2002","journal-title":"Neurology"},{"issue":"12","key":"10.14283\/jpad.2023.22_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","article-title":"Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study","volume":"56","author":"Kivipelto","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2023.22_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-0404.2002.01225.x","article-title":"Prevalence of mild cognitive impairment: a population-based study in elderly subjects","volume":"106","author":"H\u00e4nninen","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"10.14283\/jpad.2023.22_bib40","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/01.WNL.0000144281.38555.E3","article-title":"Vascular risk factors, incidence of MCI, and rates of progression to dementia","volume":"63","author":"Solfrizzi","year":"2004","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.22_bib42","author":"INSERM"},{"key":"10.14283\/jpad.2023.22_bib43","author":"Epelbaum"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:40:27Z","timestamp":1736451627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2274580724002346"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.22","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forecasting the Prevalence of Alzheimer's Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.22","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}